COVID-19 and celiac disease: a review

• Published in: Therapeutic Advances in Gastroenterology Vol. 16; p. 17562848231170944
• Main Authors: Cohen, Brandon S., Lebwohl, Benjamin
• Format: Book Review Journal Article
• Language: English
• Published: London, England SAGE Publications 01.01.2023; Sage Publications Ltd; SAGE Publishing
• Subjects: Celiac disease; COVID-19; Gastroenterology; Pandemics; The Impact of COVID-19 in Gastrointestinal Diseases; COVID-19; Celiac Disease
• ISSN: 1756-2848; 1756-283X; 1756-2848
• DOI: 10.1177/17562848231170944

The aim of this review is to broadly cover how the COVID-19 pandemic has affected individuals with celiac disease, including perceived risk, risk of contraction or severe infection, considerations regarding vaccination, access to gluten-free food during the pandemic, and possible long-term changes to the practice of celiac disease management spurred by the pandemic. While initially there was increased perceived risk about COVID-19 in the celiac disease population, studies have found that individuals with celiac disease are not at an increased risk of contracting or having a severe course compared to the general population. There is not yet evidence that COVID-19 infection will lead to an increase in celiac disease incidence, though more research on this topic with longer-term follow-up is necessary to make this determination. Limited access to in-person visits led to an increase in telemedicine, which was adopted swiftly by this patient population and may offer improved access in the long term. In summary, individuals with celiac disease do not appear to be at an increased risk of contracting COVID-19 or having a more severe disease course.